Skip to main content

Table 2 Characteristics of subclinical impairments according to the CVH score categories

From: Ideal cardiovascular health and the subclinical impairments of cardiovascular diseases: a cross-sectional study in central south China

Characteristics Poor CVH
(0–2)
Intermediate CVH (3–4) Ideal CVH
(5–7)
P Value
Number, n 1238 1423 348  
Subclinical biomarkers, median (Q1, Q3)
 Homocysteine, μmol/L 10.2 (8.3,12.3) 9.0 (7.3, 11.0) 7.5 (6.2, 9.2) <0.001
 C-reactive protein, mg/L 1.9 (1.1, 3.2) 1.3 (0.7, 2.3) 0.9 (0.58, 1.6) <0.001
 Microalbuminuria, mg/L 11.6 (6.1, 21.6) 8.6 (4.9, 14.3) 5.2 (2.0, 9.8) <0.001
Subclinical disease markers, n (%)
 1. Increased CIMT 214 (17.3) 184 (12.9) 24 (6.9) <0.001
 2. Presence of carotid plaque 396 (32.0) 364 (25.6) 45 (12.9) <0.001
 3. LV hypertrophy by ECG/echocardiography 215 (17.4) 211 (14.8) 27 (7.8) <0.001
 4. LV systolic dysfunction by echocardiography 39 (3.2) 23 (1.6) 1 (0.3) 0.001
 5. Peripheral arterial disease by ABI ≤ 0.9 22 (1.8) 13 (0.9) 0 0.012
Composite of subclinical disease markers
 At least 1, n (%) 643 (51.9) 605 (42.5) 91 (26.3) <0.001
 At least 2, n (%) 201 (16.27) 167 (11.7) 15 (4.3) <0.001
 ≥3, n (%) 31 (2.5) 24 (1.7) 1 (0.3) 0.021
 Mean score 0.71 ± 0.80 0.56 ± 0.74 0.31 ± 0.56 <0.001
  1. Q1, quartile 1; Q3, quartile 3; CVH, cardiovascular health; CIMT, carotid intima-media thickness; LV, left ventricular; BSA, body surface area; ECG, electrocardiogram; ABI, ankle-brachial index